Intrinsic Value of S&P & Nasdaq Contact Us

Radiko Holdings Corp. GEATF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
14/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Radiko Holdings Corp. (GEATF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 13/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $5M, +1643.4%/yr average growth. Net income is $11M (loss), growing at -221.8%/yr. Net profit margin is -205.5% (negative). Gross margin is -31% (-73.8 pp trend).

Balance sheet: total debt is $2M with negative equity of -$3M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.25 (tight liquidity). Debt-to-assets is 81.4%. Total assets: $3M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

GEATF SharesGrow Score Overview

34/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.00001
Volume7.89K
Avg Volume (30D)3.52K
Market Cap$4.45K
Beta (1Y)-2.86
Share Statistics
EPS (TTM)-0.04
Shares Outstanding$284.57M
IPO Date2017-11-08
CEOScott Michael Reeves
Financial Highlights & Ratios
Revenue (TTM)$5.18M
Gross Profit$-1.6M
EBITDA$-16.39M
Net Income$-10.65M
Operating Income$-10.52M
Total Cash$231.92K
Total Debt$2.21M
Net Debt$1.98M
Total Assets$2.72M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA75034R1029

Price Chart

GEATF
Radiko Holdings Corp.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message